肥胖减少肝硬化患者的肝脏相关死亡:回顾性倾向与得分匹配的研究
相关实验视频
Updated: Sep 10, 2025

08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
16.1K
Kei Endo1, Keisuke Kakisaka1, Tamami Abe1
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan.
概括
肥胖似乎通过减少与肝脏相关的死亡来改善肝硬化患者的预后. 这种保护作用在女性,非病毒性肝病患者和肉症患者中尤为明显.
科学领域:
- 肝病学
- 内部医学
- 肥胖问题研究
背景情况:
- 肝硬化预后是一个关键的临床问题.
- 肥胖对肝硬化结果的作用尚不完全理解.
- 目前的研究往往忽略了肥胖对肝硬化死亡率的具体影响.
研究的目的:
- 研究诊断肝硬化患者肥胖的预后影响.
- 区分肥胖对肝脏相关死亡率和非肝脏相关死亡率的影响.
- 确定肥胖可能影响生存的肝硬化患者的特定亚组.
主要方法:
- 在482名肝硬化患者 (不包括肝细胞癌) 进行的回顾性观察研究.
- 通过生物电阻分析定义的肥胖 (男性≥25.8%,女性≥36.5%).
- 根据关键临床因素调整的倾向性得分匹配 (n=185);在8年的随访期内分析结果.
主要成果:
- 与非肥胖患者相比,肥胖肝硬化患者的肝脏相关死亡总发病率显著降低 (P=0. 02).
- 在肥胖和非肥胖群体中,没有观察到与肝脏无关的死亡情况有显著差异 (P=0. 70).
- 多变量分析发现,肥胖与肝脏相关死亡减少 (HR,0. 49) 以及非病毒性病因,脱补血性肝硬化和肉相关.
结论:
- 在肝硬化患者中,肥胖与肝脏相关死亡风险的降低有关.
- 肥胖的这种保护作用在女性患者,非病毒病因患者和肉症患者中更为明显.
- 结果表明肥胖,肝硬化和特定患者特征之间的复杂相互作用影响了生存结果.
相关概念视频
Obesity
612
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
612
Diseases of the Liver and Gallbladder
976
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
976
Liver Physiology
1.2K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
1.2K

